Akari Therapeutics (AKTX) Tax Rate (2016 - 2026)

Name: Akari Therapeutics (AKTX) Tax Rate (2016 - 2026) | Business Quant
Creator: Business Quant

Akari Therapeutics recorded quarterly Tax Rate of 5.61% in Q1 2026, up 444.01% quarter-over-quarter from 1.63% in Q4 2025.

Akari Therapeutics' Tax Rate history runs 3 years deep, the most recent figure standing at 5.61% for Q1 2026.

In Q1 2026, Tax Rate changed N/A year-over-year to 5.61%; the TTM figure through Mar 2026 stood at 5.97% (up 597.0% YoY), while the FY2025 annual figure was 5.48%, changed N/A from the prior year.
Tax Rate came in at 5.61% for Q1 2026 at Akari Therapeutics, up from 1.63% in the prior quarter.
In the past five years, Tax Rate ranged from a high of 14.53% in Q3 2025 to a low of 1.63% in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	57.14
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	5.61
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	17.68
7	Evaxion A	62.56 Bn	62.54 Bn	-	-6.79
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	12.51
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	7.07
10	Revolution Medicines	32.39 Bn	32.39 Bn	-	-

Download Data 🔒